These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 20698994)

  • 1. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
    Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
    BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
    Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
    Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
    Choi ES; Shim JH; Jung JY; Kim HJ; Choi KH; Shin JA; Nam JS; Cho NP; Cho SD
    Cancer Sci; 2011 Apr; 102(4):742-8. PubMed ID: 21241418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxycamptothecin induces apoptosis and inhibits tumor growth in colon cancer by the downregulation of survivin and XIAP expression.
    Fei B; Chi AL; Weng Y
    World J Surg Oncol; 2013 May; 11():120. PubMed ID: 23721525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
    Azrak RG; Frank CL; Ling X; Slocum HK; Li F; Foster BA; Rustum YM
    Mol Cancer Ther; 2006 Oct; 5(10):2540-8. PubMed ID: 17041098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
    Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
    Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein.
    Shao Y; Liu Y; Shao C; Hu J; Li X; Li F; Zhang L; Zhao D; Sun L; Zhao X; Kopecko DJ; Kalvakolanu DV; Li Y; Xu DQ
    Cancer Gene Ther; 2010 Dec; 17(12):844-54. PubMed ID: 20706288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulation.
    Morikawa Y; Koike H; Sekine Y; Matsui H; Shibata Y; Ito K; Suzuki K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):584-9. PubMed ID: 22387542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin.
    Hadaschik BA; Ettinger S; Sowery RD; Zoubeidi A; Andersen RJ; Roberge M; Gleave ME
    Int J Cancer; 2008 May; 122(10):2368-76. PubMed ID: 18240145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biological implications of the inhibition of survivin by RNA interference in human androgen-independent prostate carcinoma with highly metastatic potential].
    Zhu X; Ning JY; You JF; Wang JL; Cui XL; Fang WG; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):549-54. PubMed ID: 17134550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.
    Ghadimi MP; Young ED; Belousov R; Zhang Y; Lopez G; Lusby K; Kivlin C; Demicco EG; Creighton CJ; Lazar AJ; Pollock RE; Lev D
    Clin Cancer Res; 2012 May; 18(9):2545-57. PubMed ID: 22407831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppressing the growth of Hep-2 human laryngeal cancer cells by silencing survivin gene in vitro and in vivo].
    Wen LJ; Gao LF; Ji K; Zhang HJ; Fu DN; Yang JP; Xu YP; Chen GW; Jin CS; Zhao XJ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 45(8):674-9. PubMed ID: 21055246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin inhibitor YM155 suppresses gastric cancer xenograft growth in mice without affecting normal tissues.
    Cheng XJ; Lin JC; Ding YF; Zhu L; Ye J; Tu SP
    Oncotarget; 2016 Feb; 7(6):7096-109. PubMed ID: 26771139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin.
    Hu H; Li GX; Wang L; Watts J; Combs GF; Lü J
    Clin Cancer Res; 2008 Feb; 14(4):1150-8. PubMed ID: 18281549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Rahman KM; Banerjee S; Ali S; Ahmad A; Wang Z; Kong D; Sakr WA
    Cancer Res; 2009 May; 69(10):4468-75. PubMed ID: 19435906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of monomethoxypolyethylene glycol-chitosan nanoparticle-mediated dual silencing of livin and survivin genes in prostate cancer PC-3M cells.
    Yang AQ; Wang PJ; Huang T; Zhou WL; Landman J
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection with Livin and Survivin shRNA inhibits the growth and proliferation of non‑small cell lung cancer cells.
    Huang Q; Zeng Y; Lin H; Zhang H; Yang D
    Mol Med Rep; 2017 Nov; 16(5):7086-7091. PubMed ID: 28901499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Garlic constituent diallyl trisulfide suppresses x-linked inhibitor of apoptosis protein in prostate cancer cells in culture and in vivo.
    Kim SH; Bommareddy A; Singh SV
    Cancer Prev Res (Phila); 2011 Jun; 4(6):897-906. PubMed ID: 21411500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXC receptor-1 silencing inhibits androgen-independent prostate cancer.
    Shamaladevi N; Lyn DA; Escudero DO; Lokeshwar BL
    Cancer Res; 2009 Nov; 69(21):8265-74. PubMed ID: 19861539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
    Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
    Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.